Search results for " bromide"

showing 10 items of 315 documents

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in…

2014

BACKGROUND: To further assess the safety profile of the fixed-dose combination of indacaterol and glycopyrronium (QVA149) and its monocomponents; we investigated the impact of individual patient-level factors and time by integrating the patient-level safety data from the QVA149 clinical programme with relevant information from the independent indacaterol and glycopyrronium safety databases.METHODS: Data from 11,404 patients with chronic obstructive pulmonary disease (COPD) were pooled from 14 clinical studies of QVA149, indacaterol and glycopyrronium of ≥3 month's duration with at least two of the treatment groups: QVA149 110/50 μg, glycopyrronium 50 μg, indacaterol 150 μg, placebo or tiotr…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyFixed-dose combinationScopolamine DerivativesQuinolonesPlaceboPooled analysisPulmonary Disease Chronic ObstructiveRisk FactorsInternal medicinemedicineHumansTiotropium BromideIndacaterolAgedCOPDbusiness.industryTiotropiumHazard ratioQVA149Middle Agedmedicine.diseaseGlycopyrrolateConfidence intervalBronchodilator AgentsDrug CombinationsTreatment OutcomeAnesthesiaIndansIndacaterolDrug Therapy CombinationFemaleGlycopyrroniumSafetybusinessBody mass indexMacemedicine.drugRespiratory Medicine
researchProduct

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease

2016

Abstract Background Long-term safety, particularly cardiovascular safety, is of special interest in maintenance treatment of chronic obstructive pulmonary disease (COPD) with long-acting β 2 -agonists and long-acting muscarinic antagonists, given potential cardiovascular effects. Methods Two 52-week Phase III trials (TONADO ® ) investigated tiotropium/olodaterol (5/5 and 2.5/5 μg) versus tiotropium 2.5, 5 μg and olodaterol 5 μg. In a pre-specified safety analysis, investigator-reported treatment-emergent adverse events (AEs), electrocardiogram and laboratory data were pooled. All serious AE (SAE) reports were reviewed by an independent Adjudication Committee, which assessed whether deaths, …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMedDRAComorbidityMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodForced Expiratory VolumeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineTiotropium BromideAdverse effectAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryIncidenceIncidence (epidemiology)OlodaterolTiotropium bromideMiddle Agedmedicine.diseaseComorbidityBenzoxazinesBronchodilator AgentsDrug Combinations030228 respiratory systemchemistryCardiovascular DiseasesAnesthesiaFemalebusinessMaceFollow-Up Studiesmedicine.drug
researchProduct

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease

2017

Background and purpose While the efficacy and safety of combined tiotropium and olodaterol in patients with COPD was established in a large clinical trial program, it is important to assess whether clinical data can be applied to geographic patient groups, particularly for East Asian patients who may have a different phenotypic profile to the global trial population. This study aimed to compare the lung function and safety profiles of tiotropium/olodaterol and monocomponents in East Asian and global populations from the TONADO® trials. Materials and methods In the replicate, double-blind, parallel-group, active-controlled, randomized, 52-week, Phase III TONADO studies, patients received tio…

MaleTime FactorsHealth StatusVital CapacityCholinergic AntagonistsPulmonary function testingPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicineForced Expiratory Volume030212 general & internal medicineLungLung functionOriginal ResearchCOPDeducation.field_of_studypulmonary functionOlodaterolArea under the curveGeneral MedicineMiddle AgedhumanitiesBronchodilator AgentsDrug CombinationsTreatment OutcomeArea Under CurveFemaleChinamedicine.medical_specialtyPopulationInternational Journal of Chronic Obstructive Pulmonary Disease03 medical and health sciencesAsian PeopleDouble-Blind MethodInternal medicinemedicineHumansCOPDTiotropium BromideAdverse effecteducationAdrenergic beta-2 Receptor AgonistsAgedbusiness.industryRecovery of Functionmedicine.diseaseBenzoxazinesrespiratory tract diseasesClinical trial030228 respiratory systemchemistryQuality of Lifeadverse effectsTONADO®businesshuman activitiesInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gießen, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting β2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Effect of alloying elements on the electronic properties of thin passive films formed on carbon steel, ferritic and austenitic stainless steels in a …

2014

The influence of alloying elements on the electrochemical and semiconducting properties of thin passive films formed on several steels (carbon steel, ferritic and austenitic stainless steels) has been studied in a highly concentrated lithium bromide (LiBr) solution at 25 °C, by means of potentiodynamic tests and Mott Schottky analysis. The addition of Cr to carbon steel promoted the formation of a p-type semiconducting region in the passive film. A high Ni contentmodified the electronic behaviour of highly alloyed austenitic stainless steels.Mo did notmodify the electronic structure of the passive films, but reduced the concentration of defects.

Materials scienceCarbon steelAcerElectronic structureengineering.materialElectrochemistryINGENIERIA QUIMICAStainless steelchemistry.chemical_compoundCarbon steelMaterials ChemistryElectronic propertiesAusteniteSemiconducting propertiesMott SchottkyLithium bromideMetallurgyMetals and AlloysMott schottkySurfaces and InterfacesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsThin passive filmsElectroquímicachemistrySemiconductorsengineering
researchProduct

Linear assembly of lead bromide-based nanoparticles inside lead(ii) polymers prepared by mixing the precursors of both the nanoparticle and the polym…

2019

Mixing precursors of lead(ii) polymers with those of lead bromide-based nanoparticles (CH3NH3PbBr3 perovskites or PbBr2), at room temperature and in the presence of cyclohexanemethylammonium bromide, generated colloidal nanocomposites which, when deposited on a hydrophobic surface led to long, one-dimensional, ordered and well-defined architectures. ispartof: CHEMICAL COMMUNICATIONS vol:55 issue:20 pages:2968-2971 ispartof: location:England status: published

Materials scienceChemistry MultidisciplinaryLead bromideMixing (process engineering)Nanoparticle010402 general chemistry01 natural sciencesCatalysischemistry.chemical_compoundColloidPHOTOLUMINESCENCE BLINKINGBromidePEROVSKITE NANOPARTICLESMaterials ChemistryCH3NH3PBBR3chemistry.chemical_classificationNanocompositeScience & Technology010405 organic chemistryMetals and AlloysGeneral ChemistryPolymer0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsChemistryNANOCRYSTALSchemistryChemical engineeringPhysical SciencesLUMINESCENCECeramics and CompositesFORCES
researchProduct

Paper Functionalized with Nanostructured TiO2/AgBr: Photocatalytic Degradation of 2–Propanol under Solar Light Irradiation and Antibacterial Activity

2020

A facile method to produce paper&ndash

Materials scienceGeneral Chemical EngineeringPaper-TiO2NanoparticlePropanollcsh:Chemistrychemistry.chemical_compoundsymbols.namesakeantibacterial activity2-propanol photodegradationGeneral Materials SciencePaper–TiO<sub>2</sub>–AgBrPhotodegradationPaper-TiO2-AgBr; 2-propanol photodegradation; antibacterial activity; sunlight irradiationSettore CHIM/06 - Chimica OrganicaSilver bromidesunlight irradiationTitanium oxidechemistryChemical engineeringlcsh:QD1-999PhotocatalysissymbolsRaman spectroscopy-AgBrVisible spectrumNanomaterials
researchProduct

Ultrathin lead bromide perovskite platelets spotted with europium(ii) bromide dots

2019

We describe here the preparation of a novel nanohybrid comprising a two-layer cesium lead bromide nanoplatelet, [CsPbBr3]PbBr4 NPL, containing europium(II) bromide (EuBr2) nanodots, by ultrasound/heating treatment of toluene dispersions of the CsPbBr3 nanomaterial in the presence of EuBr2 nanodots. The hybrid nanoplatelets exhibit strong excitonic and narrow emission peaks characteristic of ultrathin NPLs at 430 and 436 nm, respectively.

Materials scienceLead bromidechemistry.chemical_element02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesToluene0104 chemical sciencesNanomaterialschemistry.chemical_compoundchemistryBromideCaesiumGeneral Materials ScienceNanodot0210 nano-technologyEuropiumPerovskite (structure)Nuclear chemistryNanoscale
researchProduct

Nano-composite thermochromic thin films and their application in Energy-efficient glazing

2010

A hybrid atmospheric pressure and aerosol-assisted chemical vapour deposition strategy is presented as a facile route for the production of vanadium dioxide nano-composite thin films. The effect of the inclusion of gold nanoparticles and the use of a surfactant molecule, tetraoctylammonium bromide, is discussed. The films were fully characterised using a wide variety of techniques, including scanning electron microscopy, X-ray diffraction, X-ray photoelectron spectroscopy and UV/vis/NIR spectroscopy. It is shown that micro-structural changes brought about by careful control of film growth conditions, and/or the use of surfactant, lead to an enhancement of thermochromic properties. Gold nano…

Materials scienceRenewable Energy Sustainability and the EnvironmentAnalytical chemistryNanoparticleSettore ICAR/10 - Architettura TecnicaChemical vapor depositionengineering.materialSurfaces Coatings and FilmsElectronic Optical and Magnetic Materialschemistry.chemical_compoundGlazingX-ray photoelectron spectroscopychemistryCoatingChemical engineeringColloidal goldengineeringTetraoctylammonium bromideThin filmCVD Hybrid Aerosol Vanadium dioxide Thermochromism
researchProduct

The Antimicrobial Action of Silver Halides in Calcium Phosphate

2014

Silver halides represent a yet unexplored avenue for imparting antimicrobial activity to calcium phosphates. Negtively charged silver halide colloids (AgI, AgBr and AgCl) were added to synthesized amorphous calcium phosphate. Concurrent melting of silver halides and crystallization to carbonated apatite at 700 oC increased the silver halide surface area available to bacteria and formed a lower solubility apatite. The effect of the matrix solubility on antimicrobial response could then be investigated. Pseudomonas aeruginosa was more sensitive to silver iodide and silver bromide than Staphylococcus aureus. Silver iodide demonstrated greater activity than silver bromide. Silver chloride did n…

Materials scienceSilver halidesilver halidesMechanical EngineeringInorganic chemistrySilver iodidechemistry.chemical_elementHalideCalciumSilver bromideSilver nanoparticlechemistry.chemical_compoundSilver chlorideamorphous calcium phosphateschemistryMechanics of MaterialsapatiteantimicrobialGeneral Materials ScienceAmorphous calcium phosphatebacteriaKey Engineering Materials
researchProduct